Search
Now showing items 1-1 of 1
3-D QSAR Study Of Combretastatins Fused With Hetrocyclic Ring As Tubulin Binding Agents
(Central University of Punjab, 2018)
Combretastatin A4 (CA4) is a leading agent in vascular disrupting strategies and
tubulin polymerization inhibitor for the tumour therapy. A large number of
combretastatin derivatives have been synthesized as potent ...